STOCK TITAN

[SCHEDULE 13G] Azitra Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Alumni Capital LP, its general partner Alumni Capital GP LLC, and control person Ashkan Mapar filed a Schedule 13G reporting a deemed beneficial ownership of 2,605,586 shares of Azitra, Inc. common stock, representing 9.99% of the class. The reported position reflects shares the Fund may acquire under a Purchase Agreement and existing or to-be-issued Commitment Warrants, including a present right to acquire 849,700 shares on exercise of outstanding warrants. Ownership is subject to stated limits: a Warrant Ownership Limitation that caps ownership at 9.99% and a Purchase Agreement Ownership Limitation that currently caps purchases at 4.99% unless increased to 9.99% per the agreement.

Alumni Capital LP, il suo general partner Alumni Capital GP LLC e la persona di controllo Ashkan Mapar hanno depositato un Schedule 13G dichiarando una presunta titolarità beneficiaria di 2.605.586 azioni ordinarie di Azitra, Inc., pari al 9,99% della classe. La posizione segnalata include azioni che il Fondo può acquisire ai sensi di un Purchase Agreement e tramite Commitment Warrants già esistenti o da emettere, compreso il diritto attuale ad acquisire 849.700 azioni mediante l’esercizio di warrant in circolazione. La proprietà è soggetta a limiti indicati: un Warrant Ownership Limitation che pone un tetto al 9,99% e un Purchase Agreement Ownership Limitation che al momento limita gli acquisti al 4,99%, salvo aumento fino al 9,99% secondo quanto previsto dall’accordo.

Alumni Capital LP, su socio general Alumni Capital GP LLC y la persona de control Ashkan Mapar presentaron un Schedule 13G informando una titularidad beneficiaria considerada de 2.605.586 acciones ordinarias de Azitra, Inc., que representan el 9,99% de la clase. La posición reportada refleja acciones que el Fondo puede adquirir bajo un Purchase Agreement y Commitment Warrants existentes o por emitirse, incluyendo el derecho actual a adquirir 849.700 acciones mediante el ejercicio de warrants en circulación. La propiedad está sujeta a límites establecidos: un Warrant Ownership Limitation que fija el tope en 9,99% y un Purchase Agreement Ownership Limitation que actualmente limita las compras al 4,99%, a menos que se aumente al 9,99% según el acuerdo.

Alumni Capital LP와 그 일반 파트너 Alumni Capital GP LLC, 그리고 통제권자 Ashkan Mapar는 Schedule 13G를 제출하여 Azitra, Inc. 보통주 2,605,586주에 대한 사실상 보유를 보고했으며 이는 해당 클래스의 9.99%에 해당합니다. 보고된 보유는 펀드가 Purchase Agreement에 따라 취득할 수 있는 주식과 기존 또는 발행 예정인 Commitment Warrants를 포함하며, 현재 미결제 워런트의 행사로 849,700주를 취득할 권리가 포함되어 있습니다. 보유는 명시된 제한의 적용을 받습니다: 보유를 9.99%로 제한하는 Warrant Ownership Limitation과 현재 구매를 4.99%로 제한하되 계약에 따라 9.99%로 상향할 수 있는 Purchase Agreement Ownership Limitation이 있습니다.

Alumni Capital LP, son associé commandité Alumni Capital GP LLC et la personne de contrôle Ashkan Mapar ont déposé un Schedule 13G déclarant une détention réputée bénéficiaire de 2 605 586 actions ordinaires d’Azitra, Inc., représentant 9,99% de la catégorie. La position déclarée comprend des actions que le Fonds peut acquérir en vertu d’un Purchase Agreement ainsi que des Commitment Warrants existants ou à émettre, y compris le droit actuel d’acquérir 849 700 actions par l’exercice de warrants en circulation. La détention est soumise aux limites indiquées : une Warrant Ownership Limitation plafonnant la participation à 9,99% et une Purchase Agreement Ownership Limitation qui limite actuellement les achats à 4,99%, sauf augmentation à 9,99% conformément à l’accord.

Alumni Capital LP, dessen General Partner Alumni Capital GP LLC und die kontrollierende Person Ashkan Mapar reichten ein Schedule 13G ein und meldeten eine als vorteilhaft angesehene Beteiligung von 2.605.586 Aktien der Stammaktien von Azitra, Inc., was 9,99% der Klasse entspricht. Die gemeldete Position umfasst Aktien, die der Fonds gemäß einem Purchase Agreement erwerben kann, sowie bestehende oder noch auszugebende Commitment Warrants, einschließlich des gegenwärtigen Rechts, durch Ausübung ausstehender Warrants 849.700 Aktien zu erwerben. Das Eigentum unterliegt den angegebenen Beschränkungen: einer Warrant Ownership Limitation, die die Beteiligung auf 9,99% begrenzt, und einer Purchase Agreement Ownership Limitation, die Käufe derzeit auf 4,99% beschränkt, es sei denn, sie wird gemäß Vereinbarung auf 9,99% erhöht.

Positive
  • Clear disclosure of deemed beneficial ownership (2,605,586 shares, 9.99%) via Schedule 13G filing
  • Specifies contractual rights and limits: Purchase Agreement and Commitment Warrants with explicit ownership caps
  • Quantifies warrant exposure: right to acquire 849,700 shares via outstanding Commitment Warrants
  • Includes certifications and signatures confirming accuracy and joint filing agreement
Negative
  • No current outright ownership—the Fund does not own shares as of the filing date, holdings are contingent rights
  • Ownership subject to multiple limits (Warrant Ownership Limitation at 9.99% and Purchase Agreement Ownership Limitation at 4.99% unless increased)
  • Shared voting/dispositive power only; reporting persons report 0 sole voting or dispositive power

Insights

TL;DR: Reporting persons disclose a near-10% economic interest via warrants and an agreement, creating potential future share acquisition but no current outright ownership.

The filing reports 2,605,586 shares deemed beneficial under Rule 13d-3 because of a Purchase Agreement and Commitment Warrants. The Fund currently does not own shares outright but has the right to acquire 849,700 shares via outstanding warrants. The filing explicitly notes ownership ceilings: a 9.99% cap for warrants and a 4.99% purchase cap that can be raised to 9.99% with issuer consent or agreement. This is a controlled, contractual pathway to reach economic exposure without immediate voting or dispositive sole power.

TL;DR: Disclosure clarifies control relationships and contractual limits, complying with Schedule 13G requirements while disclaiming active control.

The filing identifies the reporting entities, their addresses, and citizenships, and states that the General Partner and controlling person share voting and dispositive power over the reported shares. Signatures by Ashkan Mapar certify the statements and include a joint filing agreement. The Certification asserts the position was not acquired to influence control. The disclosure of explicit ownership limits and the pecuniary-interest disclaimer are important governance details for shareholders assessing potential influence.

Alumni Capital LP, il suo general partner Alumni Capital GP LLC e la persona di controllo Ashkan Mapar hanno depositato un Schedule 13G dichiarando una presunta titolarità beneficiaria di 2.605.586 azioni ordinarie di Azitra, Inc., pari al 9,99% della classe. La posizione segnalata include azioni che il Fondo può acquisire ai sensi di un Purchase Agreement e tramite Commitment Warrants già esistenti o da emettere, compreso il diritto attuale ad acquisire 849.700 azioni mediante l’esercizio di warrant in circolazione. La proprietà è soggetta a limiti indicati: un Warrant Ownership Limitation che pone un tetto al 9,99% e un Purchase Agreement Ownership Limitation che al momento limita gli acquisti al 4,99%, salvo aumento fino al 9,99% secondo quanto previsto dall’accordo.

Alumni Capital LP, su socio general Alumni Capital GP LLC y la persona de control Ashkan Mapar presentaron un Schedule 13G informando una titularidad beneficiaria considerada de 2.605.586 acciones ordinarias de Azitra, Inc., que representan el 9,99% de la clase. La posición reportada refleja acciones que el Fondo puede adquirir bajo un Purchase Agreement y Commitment Warrants existentes o por emitirse, incluyendo el derecho actual a adquirir 849.700 acciones mediante el ejercicio de warrants en circulación. La propiedad está sujeta a límites establecidos: un Warrant Ownership Limitation que fija el tope en 9,99% y un Purchase Agreement Ownership Limitation que actualmente limita las compras al 4,99%, a menos que se aumente al 9,99% según el acuerdo.

Alumni Capital LP와 그 일반 파트너 Alumni Capital GP LLC, 그리고 통제권자 Ashkan Mapar는 Schedule 13G를 제출하여 Azitra, Inc. 보통주 2,605,586주에 대한 사실상 보유를 보고했으며 이는 해당 클래스의 9.99%에 해당합니다. 보고된 보유는 펀드가 Purchase Agreement에 따라 취득할 수 있는 주식과 기존 또는 발행 예정인 Commitment Warrants를 포함하며, 현재 미결제 워런트의 행사로 849,700주를 취득할 권리가 포함되어 있습니다. 보유는 명시된 제한의 적용을 받습니다: 보유를 9.99%로 제한하는 Warrant Ownership Limitation과 현재 구매를 4.99%로 제한하되 계약에 따라 9.99%로 상향할 수 있는 Purchase Agreement Ownership Limitation이 있습니다.

Alumni Capital LP, son associé commandité Alumni Capital GP LLC et la personne de contrôle Ashkan Mapar ont déposé un Schedule 13G déclarant une détention réputée bénéficiaire de 2 605 586 actions ordinaires d’Azitra, Inc., représentant 9,99% de la catégorie. La position déclarée comprend des actions que le Fonds peut acquérir en vertu d’un Purchase Agreement ainsi que des Commitment Warrants existants ou à émettre, y compris le droit actuel d’acquérir 849 700 actions par l’exercice de warrants en circulation. La détention est soumise aux limites indiquées : une Warrant Ownership Limitation plafonnant la participation à 9,99% et une Purchase Agreement Ownership Limitation qui limite actuellement les achats à 4,99%, sauf augmentation à 9,99% conformément à l’accord.

Alumni Capital LP, dessen General Partner Alumni Capital GP LLC und die kontrollierende Person Ashkan Mapar reichten ein Schedule 13G ein und meldeten eine als vorteilhaft angesehene Beteiligung von 2.605.586 Aktien der Stammaktien von Azitra, Inc., was 9,99% der Klasse entspricht. Die gemeldete Position umfasst Aktien, die der Fonds gemäß einem Purchase Agreement erwerben kann, sowie bestehende oder noch auszugebende Commitment Warrants, einschließlich des gegenwärtigen Rechts, durch Ausübung ausstehender Warrants 849.700 Aktien zu erwerben. Das Eigentum unterliegt den angegebenen Beschränkungen: einer Warrant Ownership Limitation, die die Beteiligung auf 9,99% begrenzt, und einer Purchase Agreement Ownership Limitation, die Käufe derzeit auf 4,99% beschränkt, es sei denn, sie wird gemäß Vereinbarung auf 9,99% erhöht.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Alumni Capital LP
Signature:/s/ Ashkan Mapar
Name/Title:Ashkan Mapar/Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
Date:08/20/2025
Alumni Capital GP LLC
Signature:/s/ Ashkan Mapar
Name/Title:Ashkan Mapar/Manager
Date:08/20/2025
Ashkan Mapar
Signature:/s/ Ashkan Mapar
Name/Title:Ashkan Mapar
Date:08/20/2025
Exhibit Information

A. Agreement of Joint Filing

FAQ

How many Azitra (AZTR) shares are reported and what percent of the class does that represent?

The reporting persons state beneficial ownership of 2,605,586 shares, representing 9.99% of Azitra's common stock as reported in this Schedule 13G.

Does Alumni Capital currently own the reported Azitra shares outright?

No. The filing states the Fund does not own any Shares as of the date of the filing; the reported amount reflects shares the Fund may acquire under contractual arrangements.

How many shares can the Fund acquire via outstanding warrants?

The filing specifies the Fund has the right to acquire 849,700 shares upon exercise of outstanding Commitment Warrants.

What ownership limits apply to the Fund under the agreements?

Two limits are disclosed: a Warrant Ownership Limitation capping beneficial ownership via warrants at 9.99%, and a Purchase Agreement Ownership Limitation that currently caps purchases at 4.99% but may be increased to 9.99% with issuer consent or written agreement.

Who are the reporting persons and where are they located?

The reporting persons are Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar; their principal business office is 601 Brickell Key Dr., Suite 700, Miami, FL 33131.

What outstanding share count did the filing reference when calculating the percentage?

The percent calculation is based on the Issuer's Quarterly Report filed with the SEC reporting 23,476,354 shares outstanding as of August 11, 2025, plus potential shares from the warrants and Purchase Agreement as described.
Azitra Inc

NYSE:AZTR

AZTR Rankings

AZTR Latest News

AZTR Latest SEC Filings

AZTR Stock Data

3.40M
21.83M
7%
3.42%
4.47%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRANFORD